Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:
A young man sits at his desk working on his laptop with a big smile on his face due to his ASX shares going up and in particular the Computershare share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Beach Energy Ltd (ASX: BPT)

According to a note out of Bell Potter, its analysts have retained their buy rating on this energy producer's shares with a trimmed price target of $1.90. This follows the release of a quarterly update which fell short on production but beat on sales volumes. Bell Potter remains very positive on the company due to its favourable view on the Australian east coast gas and LNG markets and its strong earnings growth outlook. The Beach Energy share price is trading at $1.63 today.

Paladin Energy Ltd (ASX: PDN)

A note out of Citi reveals that its analysts have upgraded this uranium producer's shares to a buy rating with an improved price target of $1.45. The broker made the move in response to the company's quarterly update and higher uranium price assumptions. It has lifted the latter to reflect ongoing mine development issues in Africa and Kazakhstan. The Paladin Energy share price is fetching $1.21 on Monday.

ResMed Inc (ASX: RMD)

Analysts at Goldman Sachs have reiterated their buy rating on this sleep treatment company's shares with an improved price target of $33.50. The broker was impressed with ResMed's quarterly update and remains very bullish on its outlook. In light of this, its continues to see asymmetric upside risk at current valuations. The ResMed share price is currently trading at $28.58.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Buy and sell keys on an Apple keyboard.
Broker Notes

1 ASX 200 share to buy and 1 to sell now

Goldman Sachs has given its verdict on these two stocks.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Broker Notes

Buy this undervalued ASX 200 stock for a 40%+ return

Goldman Sachs thinks this stock is heading a lot higher.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Morgans says these 3 ASX 200 shares are buys

If you are looking for some new ASX 200 shares to buy, then read on! That's because the three named…

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

5 ASX stocks for $5,000 investments in December

Let's find out which shares brokers are tipping as buys right now.

Read more »

A woman wearing a yellow shirt smiles as she checks her phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Broker Notes

3 ASX shares catching broker upgrades this week

Analysts are turning more constructive on these names.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Technology Shares

Is the WiseTech share price heading for $200?

The path is set, according to one broker.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Goldman Sachs says these ASX 300 stocks can rise 15% to 30%

Let's see what the broker is saying about these buy-rated stocks.

Read more »